Table 1. Comparison of demographics and clinical data between groups.
| STEMI (n = 21) | NSTEMI (n = 24) | UA (n = 30) | Controls (n = 20) | P value | |
| Age, years | 61.3±10.6 | 62.4±9.6 | 60.7±8.9 | 60.4±10.3 | ns |
| Gender, male, number (%) | 13 (62%) | 16 (67%) | 19 (63%) | 12 (60%) | ns |
| Previous history of CAD | 5 (24%) | 5 (21%) | 2 (7%) | ||
| Cardiovascular risk factors, n (%) | |||||
| Hypertension, (>140/90 mm Hg) | 13 (62) | 14 (58%) | 11 (37%) | 0 | <0.05 |
| Diabetes mellitus | 12 (57%) | 12 (50%) | 6 (20%) | 0 | <0.01 |
| Current smoking | 5 (24%) | 6 (25%) | 6 (20%) | 0 | ns |
| Cholesterolemia>5.17 mmol/L | 7 (33%) | 9 (37%) | 8 (27%) | 0 | ns |
| Family history of CAD | 3 (14%) | 4 (17%) | 4 (13%) | 0 | ns |
| At least 3 risk factors | 8 (38%) | 8 (33%) | 3 (10%) | 0 | ns |
| Previous history of CAD | 4 (19%) | 4 (17%) | 2 (7%) | 0 | ns |
| Cardiac catheterization | |||||
| Vessel score | 2.1±0.8 | 1.6±0.8 | 1.1±0.6 | — | <0.05 |
| Laboratory data and follow-up | |||||
| Leukocyte count (x 109/mL) | 13.1±2.48 | 12.7±2.24 | 8.8±1.75 | 7.5±1.46 | <0.01 |
| Creatinine (µmol/L) | 72.4±15.6 | 71.5±14.3 | 70.4±16.2 | 69.8±14.7 | ns |
| Glucose (mmol/L) | 6.4±1.17 | 6.2±1.02 | 5.54±0.94 | 5.30±0.45 | <0.05 |
| Troponin I peak level (ng/mL) | 84±23 | 76±25 | 18±10 | <6.0 | <0.001 |
| CRP (mg/dl) | 14.24±5.09 | 10.60±2.10 | 9.54±2.28 | <0.001 | |
| IL6 (ng/L) | 12.33±2.90 | 10.75±2.20 | 8.77±2.09 | <0.001 | |
| BNP (pg/ml) | 482±255 | 364±191 | 58±37 | <0.001 | |
| Infectious episodes within 2 months after discharge | 4 (19%) | 3 (12%) | 0 | <0.01 | |
| Fatal MI during the first year | 1 (5%) | 1 (4%) | 0 | ns |
Data are Mean±SD, IQR or number (%). STEMI or NSTEMI vs. UA patients (ANOVA/Dunn). ns: non-significant; CRP: C-reactive protein; IQR: interquartile range; BNP: Brain natriuretic peptide.